Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.1%

49 terminated/withdrawn out of 964 trials

Success Rate

89.5%

+2.9% vs industry average

Late-Stage Pipeline

9%

89 trials in Phase 3/4

Results Transparency

12%

50 of 417 completed trials have results

Key Signals

118 recruiting50 with results31 terminated18 withdrawn

Enrollment Performance

Analytics

N/A
364(55.7%)
Phase 2
127(19.4%)
Phase 3
73(11.2%)
Phase 1
68(10.4%)
Phase 4
16(2.5%)
Early Phase 1
5(0.8%)
653Total
N/A(364)
Phase 2(127)
Phase 3(73)
Phase 1(68)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (964)

Showing 20 of 964 trials
NCT07813351Phase 3Not Yet Recruiting

PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours

Role: lead

NCT07843433Not Yet Recruiting

ImprovINg the TIMEly Diagnosis and Treatment of Cancer and Cardio-metabolic Diseases in People With Mental Disorders: Reducing Health Disparities Through Integrated Care

Role: collaborator

NCT05880160Not ApplicableCompleted

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

Role: lead

NCT05640999Phase 2Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Role: collaborator

NCT03425565Phase 2Completed

A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer

Role: lead

NCT07347275Not ApplicableRecruiting

A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.

Role: collaborator

NCT05414383Not Yet Recruiting

A Prospective Study to Evaluate the Diagnostic Accuracy of Computer-aided Diagnosis (CADx) System in Real-time Characterization of Colorectal Neoplasia

Role: collaborator

NCT06890039Phase 2Recruiting

A-TANGO Phase 2 Study

Role: collaborator

NCT07831902Phase 3Recruiting

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer

Role: lead

NCT03299426Phase 3Active Not Recruiting

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Role: collaborator

NCT07820553Not Yet Recruiting

Building a Computational Model of Auditory Hallucinations

Role: collaborator

NCT05197322Phase 2Active Not Recruiting

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Role: lead

NCT07815470Not ApplicableActive Not Recruiting

Dancing as an Alternative to the Traditional Exercising in Older Adults With Cardiac Diseases

Role: lead

NCT07539259Phase 2Not Yet Recruiting

Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis

Role: lead

NCT06921213Phase 2Recruiting

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Role: collaborator

NCT07810283Enrolling By Invitation

The Feasibility of Electrical Impedance Tomography to Guide Non-invasive Respiratory Interventions in Chronic Respiratory Disease

Role: collaborator

NCT07808528Not ApplicableNot Yet Recruiting

Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)

Role: lead

NCT07751133Phase 3Recruiting

Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

Role: lead

NCT05947786Completed

Mpox Paediatric and Adolescent Clinical Study

Role: collaborator

NCT05622669Completed

Understanding Patterns of Fatigue in Health and Disease

Role: collaborator